PDCD1 and non-small cell lung carcinoma: We then applied such quantification method on the pre-treatment FFPE biopsies samples of a pilot retrospective cohort of NSCLC treated with PD-1/PD-L1 blockade (N=20) and found that the abundance of these CD39+CD8+ T cells population are of predictive value.